17.27 USD
-0.75 (-4.16%)
17.27 USD
0 (0%)
Taking everything into account, NRC scores 4 out of 10 in our fundamental rating. NRC was compared to 101 industry peers in the Health Care Providers & Services industry. NRC scores excellent on profitability, but there are concerns on its financial health. NRC is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year NRC was profitable.
NRC had a positive operating cash flow in the past year.
NRC had positive earnings in each of the past 5 years.
In the past 5 years NRC always reported a positive cash flow from operatings.
1.2 Ratios
NRC's Return On Assets of 12.06% is amongst the best of the industry. NRC outperforms 98.02% of its industry peers.
With an excellent Return On Equity value of 114.31%, NRC belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
The Return On Invested Capital of NRC (23.31%) is better than 96.04% of its industry peers.
NRC had an Average Return On Invested Capital over the past 3 years of 37.15%. This is significantly above the industry average of 9.27%.
The last Return On Invested Capital (23.31%) for NRC is well below the 3 year average (37.15%), which needs to be investigated, but indicates that NRC had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.06% | ||
| ROE | 114.31% | ||
| ROIC | 23.31% |
ROA(3y)22.78%
ROA(5y)24%
ROE(3y)62.21%
ROE(5y)57.67%
ROIC(3y)37.15%
ROIC(5y)35.26%
1.3 Margins
The Profit Margin of NRC (11.76%) is better than 99.01% of its industry peers.
In the last couple of years the Profit Margin of NRC has declined.
The Operating Margin of NRC (21.24%) is better than 96.04% of its industry peers.
NRC's Operating Margin has declined in the last couple of years.
The Gross Margin of NRC (62.05%) is better than 81.19% of its industry peers.
In the last couple of years the Gross Margin of NRC has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 21.24% | ||
| PM (TTM) | 11.76% | ||
| GM | 62.05% |
OM growth 3Y-10.18%
OM growth 5Y-5.95%
PM growth 3Y-11.83%
PM growth 5Y-7.25%
GM growth 3Y-2.32%
GM growth 5Y-1.11%
2. Health
2.1 Basic Checks
NRC has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for NRC has been reduced compared to 1 year ago.
Compared to 5 years ago, NRC has less shares outstanding
The debt/assets ratio for NRC is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 3.39 indicates that NRC is not in any danger for bankruptcy at the moment.
NRC has a Altman-Z score of 3.39. This is in the better half of the industry: NRC outperforms 70.30% of its industry peers.
NRC has a debt to FCF ratio of 6.89. This is a slightly negative value and a sign of low solvency as NRC would need 6.89 years to pay back of all of its debts.
NRC's Debt to FCF ratio of 6.89 is in line compared to the rest of the industry. NRC outperforms 59.41% of its industry peers.
NRC has a Debt/Equity ratio of 5.31. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 5.31, NRC is doing worse than 80.20% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 5.31 | ||
| Debt/FCF | 6.89 | ||
| Altman-Z | 3.39 |
ROIC/WACC2.7
WACC8.64%
2.3 Liquidity
A Current Ratio of 0.53 indicates that NRC may have some problems paying its short term obligations.
NRC has a Current ratio of 0.53. This is amonst the worse of the industry: NRC underperforms 87.13% of its industry peers.
NRC has a Quick Ratio of 0.53. This is a bad value and indicates that NRC is not financially healthy enough and could expect problems in meeting its short term obligations.
NRC has a Quick ratio of 0.53. This is amonst the worse of the industry: NRC underperforms 85.15% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.53 | ||
| Quick Ratio | 0.53 |
3. Growth
3.1 Past
The earnings per share for NRC have decreased strongly by -36.45% in the last year.
Measured over the past years, NRC shows a decrease in Earnings Per Share. The EPS has been decreasing by -3.70% on average per year.
The Revenue has decreased by -3.50% in the past year.
The Revenue has been growing slightly by 2.25% on average over the past years.
EPS 1Y (TTM)-36.45%
EPS 3Y-10.59%
EPS 5Y-3.7%
EPS Q2Q%-22.25%
Revenue 1Y (TTM)-3.5%
Revenue growth 3Y-1.13%
Revenue growth 5Y2.25%
Sales Q2Q%-3.38%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 24.32, the valuation of NRC can be described as rather expensive.
62.38% of the companies in the same industry are more expensive than NRC, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 26.15, NRC is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.32 | ||
| Fwd PE | N/A |
4.2 Price Multiples
63.37% of the companies in the same industry are more expensive than NRC, based on the Enterprise Value to EBITDA ratio.
NRC's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 34.27 | ||
| EV/EBITDA | 13.03 |
4.3 Compensation for Growth
NRC has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
NRC has a Yearly Dividend Yield of 3.85%.
NRC's Dividend Yield is rather good when compared to the industry average which is at 2.60. NRC pays more dividend than 99.01% of the companies in the same industry.
NRC's Dividend Yield is rather good when compared to the S&P500 average which is at 2.41.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.85% |
5.2 History
The dividend of NRC decreases each year by -17.40%.
NRC has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-17.4%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
NRC pays out 67.82% of its income as dividend. This is not a sustainable payout ratio.
The Dividend Rate of NRC has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP67.82%
EPS Next 2YN/A
EPS Next 3YN/A
17.27
-0.75 (-4.16%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners51.36%
Inst Owner Change-4.54%
Ins Owners9.51%
Ins Owner Change10.15%
Market Cap398.25M
Revenue(TTM)139.10M
Net Income(TTM)16.36M
Analysts45
Price TargetN/A
Short Float %3.21%
Short Ratio3.86
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.85% |
Yearly Dividend0.48
Dividend Growth(5Y)-17.4%
DP67.82%
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.32 | ||
| Fwd PE | N/A | ||
| P/S | 2.86 | ||
| P/FCF | 34.27 | ||
| P/OCF | 15.53 | ||
| P/B | 27.82 | ||
| P/tB | N/A | ||
| EV/EBITDA | 13.03 |
EPS(TTM)0.71
EY4.11%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.5
FCFY2.92%
OCF(TTM)1.11
OCFY6.44%
SpS6.03
BVpS0.62
TBVpS-2.35
PEG (NY)N/A
PEG (5Y)N/A
Graham Number3.15
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.06% | ||
| ROE | 114.31% | ||
| ROCE | 30.4% | ||
| ROIC | 23.31% | ||
| ROICexc | 23.85% | ||
| ROICexgc | 85.58% | ||
| OM | 21.24% | ||
| PM (TTM) | 11.76% | ||
| GM | 62.05% | ||
| FCFM | 8.35% |
ROA(3y)22.78%
ROA(5y)24%
ROE(3y)62.21%
ROE(5y)57.67%
ROIC(3y)37.15%
ROIC(5y)35.26%
ROICexc(3y)44.09%
ROICexc(5y)48.46%
ROICexgc(3y)273.96%
ROICexgc(5y)N/A
ROCE(3y)48.46%
ROCE(5y)46%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y-21.97%
ROICexc growth 5Y-12.09%
OM growth 3Y-10.18%
OM growth 5Y-5.95%
PM growth 3Y-11.83%
PM growth 5Y-7.25%
GM growth 3Y-2.32%
GM growth 5Y-1.11%
F-Score6
Asset Turnover1.02
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 5.31 | ||
| Debt/FCF | 6.89 | ||
| Debt/EBITDA | 2.08 | ||
| Cap/Depr | 200.56% | ||
| Cap/Sales | 10.09% | ||
| Interest Coverage | 7.64 | ||
| Cash Conversion | 70.21% | ||
| Profit Quality | 71.02% | ||
| Current Ratio | 0.53 | ||
| Quick Ratio | 0.53 | ||
| Altman-Z | 3.39 |
F-Score6
WACC8.64%
ROIC/WACC2.7
Cap/Depr(3y)236.79%
Cap/Depr(5y)169.97%
Cap/Sales(3y)9.3%
Cap/Sales(5y)6.92%
Profit Quality(3y)77.54%
Profit Quality(5y)88.07%
High Growth Momentum
Growth
EPS 1Y (TTM)-36.45%
EPS 3Y-10.59%
EPS 5Y-3.7%
EPS Q2Q%-22.25%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.5%
Revenue growth 3Y-1.13%
Revenue growth 5Y2.25%
Sales Q2Q%-3.38%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-21.79%
EBIT growth 3Y-11.19%
EBIT growth 5Y-3.83%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-43.42%
FCF growth 3Y-22.27%
FCF growth 5Y-11.96%
OCF growth 1Y-25.7%
OCF growth 3Y-9.26%
OCF growth 5Y-3.29%
NATIONAL RESEARCH CORP / NRC FAQ
What is the ChartMill fundamental rating of NATIONAL RESEARCH CORP (NRC) stock?
ChartMill assigns a fundamental rating of 4 / 10 to NRC.
What is the valuation status for NRC stock?
ChartMill assigns a valuation rating of 3 / 10 to NATIONAL RESEARCH CORP (NRC). This can be considered as Overvalued.
What is the profitability of NRC stock?
NATIONAL RESEARCH CORP (NRC) has a profitability rating of 8 / 10.
How financially healthy is NATIONAL RESEARCH CORP?
The financial health rating of NATIONAL RESEARCH CORP (NRC) is 3 / 10.
Is the dividend of NATIONAL RESEARCH CORP sustainable?
The dividend rating of NATIONAL RESEARCH CORP (NRC) is 5 / 10 and the dividend payout ratio is 67.82%.